|
National Stock Number(NSN): 6505-01-376-6538 (6505013766538, 013766538)
| NIIN: |
01-376-6538 |
Item Name: |
CEFADROXIL TABLETS |
INC: |
36903
|
| FSC: |
6505
|
Assignment Date: |
Jun-06-1993 |
CRIT: |
N |
IIG: |
36903 |
| ISC: |
2 |
Date Standardized: |
Jun-06-1993 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Feb-01-2002 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
DURICEF |
0NWX1
|
BRISTOL-MYERS SQUIBB PHARMACEUTICAL GROUP SQUIBB US PHARMACEUTICAL DIV |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
DURICEF |
0XPK1
|
PRINCETON PHARMACEUTICAL PRODUCTS A BRISTOL-MYERS SQUIBB CO |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
DURICEF TABLETS |
0XPK1
|
PRINCETON PHARMACEUTICAL PRODUCTS A BRISTOL-MYERS SQUIBB CO |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
L93-207 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00087-0785-44 |
0NWX1
|
BRISTOL-MYERS SQUIBB PHARMACEUTICAL GROUP SQUIBB US PHARMACEUTICAL DIV |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00087-0785-44 |
0XPK1
|
PRINCETON PHARMACEUTICAL PRODUCTS A BRISTOL-MYERS SQUIBB CO |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
M |
U |
1 |
A |
$875.90 |
PG |
|
C2201X- |
Oct-01-2001 |
H |
| DF |
S9M |
H |
|
M |
U |
1 |
F |
$875.90 |
PG |
|
------- |
Oct-01-2001 |
H |
| DN |
S9M |
H |
|
M |
U |
1 |
N |
$875.90 |
PG |
|
9L----- |
Oct-01-2001 |
H |
| DS |
S9M |
H |
|
M |
U |
1 |
D |
$875.90 |
PG |
|
------- |
Oct-01-2001 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DA |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DF |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DN |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DS |
R |
REFER TO EDI ITEM |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
1.000 GRAMS CEFADROXIL ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
UNIT DOSE |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
100.000 TABLETS |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
May-20-2000 |
3 |
H |
|
|
|
|
| FSKX |
|
May-20-2000 |
3 |
H |
|
|
|
|
| N9LM |
|
May-20-2000 |
3 |
H |
|
|
|
|
|